Literature DB >> 10388496

National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases.

A H Wu1, F S Apple, W B Gibler, R L Jesse, M M Warshaw, R Valdes.   

Abstract

The Sixth Conference on the "Standards of Laboratory Practice Series", sponsored by the National Academy of Clinical Biochemistry (NACB), was held on August 4-5, 1998, at the Annual Meeting of the American Association for Clinical Chemistry, in Chicago, IL. An expert committee was assembled to write recommendations on the use of cardiac markers in coronary artery diseases. The NACB Committee prepared a preliminary draft of the guidelines, made them available on the World Wide Web (www.nacb.org), and distributed them before the presentations. The recommendations were divided into four areas: the use of markers in the triage of patients with chest pain, acute coronary syndromes, clinical applications other than acute myocardial infarction and research, and assay platforms and markers of acute myocardial infarction. The recommendations were revised and subsequently re-presented in part at the "Biomarkers in Acute Cardiac Syndromes Conference", sponsored by the Jewish Hospital Heart and Lung Institute, Louisville KY, on October 16-17, 1998. This report lists each recommendation, its scientific justification, and a summary of discussions from conference participants and reviewers. Approximately 100 individuals responded to various versions of these recommendations via direct correspondences, telephone calls to Committee members, electronic mail correspondence to the Committee Chairman, or oral questions and comments raised during one of the two conference presentations. Some of the recommendations were changed to reflect the consensus opinion. In cases in which there was no consensus, the Committee included pertinent discussion without necessarily changing the original recommendations. At times, the Committee members felt that although a particular recommendation might not be the current standard of care today, they anticipate that it likely will be adopted in the near future.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10388496

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  68 in total

1.  Multicentre evaluation of the diagnostic value of cardiac troponin T, CK-MB mass, and myoglobin for assessing patients with suspected acute coronary syndromes in routine clinical practice.

Authors:  P O Collinson; P J Stubbs; A-C Kessler
Journal:  Heart       Date:  2003-03       Impact factor: 5.994

2.  Sources of variability in measurements of cardiac troponin T in a community-based sample: the atherosclerosis risk in communities study.

Authors:  Sunil K Agarwal; Christy L Avery; Christie M Ballantyne; Diane Catellier; Vijay Nambi; Justin Saunders; A Richey Sharrett; Josef Coresh; Gerardo Heiss; Ron C Hoogeveen
Journal:  Clin Chem       Date:  2011-04-25       Impact factor: 8.327

3.  Myocardial infarction: redefined or reinvented?

Authors:  H Dargie
Journal:  Heart       Date:  2002-07       Impact factor: 5.994

4.  [The incorrect laboratory result. Part 1: Pre- and postanalytical phase].

Authors:  G M Fiedler; J Thiery
Journal:  Internist (Berl)       Date:  2004-03       Impact factor: 0.743

5.  Troponin I, laboratory issues, and clinical outcomes in a district general hospital: crossover study with "traditional" markers of myocardial infarction in a total of 1990 patients.

Authors:  F Jishi; P R Hudson; C P Williams; R P Jones; G K Davies; Z R Yousef; R J Trent; R P W Cowell
Journal:  J Clin Pathol       Date:  2004-10       Impact factor: 3.411

6.  Surface plasmon resonance aided electrochemical immunosensor for CK-MB determination in undiluted serum samples.

Authors:  Fernando Garay; Greggory Kisiel; Aiping Fang; Erno Lindner
Journal:  Anal Bioanal Chem       Date:  2010-05-08       Impact factor: 4.142

Review 7.  Are There Deleterious Cardiac Effects of Acute and Chronic Endurance Exercise?

Authors:  Thijs M H Eijsvogels; Antonio B Fernandez; Paul D Thompson
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

8.  Clinical chemistry through Clinical Chemistry: a journal timeline.

Authors:  Robert Rej
Journal:  Clin Chem       Date:  2004-12       Impact factor: 8.327

Review 9.  Redefining myocardial infarction for the 21st century.

Authors:  Joseph S Alpert; Beth R Malasky; Kristian Thygesen
Journal:  Trans Am Clin Climatol Assoc       Date:  2004

10.  Do immature platelet levels in chest pain patients presenting to the emergency department aid in the diagnosis of acute coronary syndrome?

Authors:  M A Berny-Lang; C E Darling; A L Frelinger; M R Barnard; C S Smith; A D Michelson
Journal:  Int J Lab Hematol       Date:  2014-05-08       Impact factor: 2.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.